Dillon & Associates Inc. Sells 5,947 Shares of Colgate-Palmolive (NYSE:CL)

Dillon & Associates Inc. lessened its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 13.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,029 shares of the company’s stock after selling 5,947 shares during the period. Dillon & Associates Inc.’s holdings in Colgate-Palmolive were worth $3,122,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth lifted its stake in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth $32,000. McGlone Suttner Wealth Management Inc. bought a new stake in Colgate-Palmolive during the fourth quarter worth $34,000. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its stake in Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CL has been the subject of several recent analyst reports. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Stifel Nicolaus upped their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, April 29th. Wells Fargo & Company upped their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Monday, April 29th. Royal Bank of Canada upped their target price on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Monday, April 29th. Finally, Barclays upped their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Three equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $92.35.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Trading Down 0.4 %

NYSE CL traded down $0.40 on Friday, reaching $94.13. The company had a trading volume of 4,135,238 shares, compared to its average volume of 4,852,708. The firm has a market cap of $77.23 billion, a price-to-earnings ratio of 29.79, a P/E/G ratio of 3.48 and a beta of 0.40. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $95.59. The business has a 50 day moving average of $89.81 and a two-hundred day moving average of $83.70. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 earnings per share. Analysts forecast that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd were given a dividend of $0.50 per share. The ex-dividend date was Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.12%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares of the company’s stock, valued at $5,054,629.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Jennifer Daniels sold 3,538 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 89,209 shares of company stock valued at $7,667,425. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.